Millennium Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-360,000
Closed -$6.16M 7667
2021
Q3
$6.16M Buy
360,000
+260,000
+260% +$4.05M ﹤0.01% 2622
2021
Q2
$1.34M Buy
+100,000
New +$2.46M ﹤0.01% 4389
2019
Q4
Sell
-303,400
Closed -$2.06M 4772
2019
Q3
$2.06M Hold
303,400
﹤0.01% 2425
2019
Q2
$2.82M Buy
+303,400
New +$3.51M ﹤0.01% 2198
2013
Q4
Sell
-151,900
Closed -$845K 3886
2013
Q3
$845K Buy
+151,900
New +$1.64M ﹤0.01% 2227

Other funds holding CCXI

Millennium Management's CCXI Position: Q4 2022 in Review

Millennium Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 983,809 shares — an estimated $50.8M sold.

Millennium Management first reported a position in CCXI in Q2 2013 and held it in 33 quarters. The position peaked at $50.8M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Millennium Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Millennium Management sold 983,809 ChemoCentryx, Inc. shares in Q4 2022, an estimated $50.8M.
  • Millennium Management first reported a position in ChemoCentryx, Inc. in Q2 2013 and held it in 33 quarters.
  • Millennium Management's ChemoCentryx, Inc. position peaked at $50.8M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.